Hepatocellular Carcinoma Surveillance: Are We Utilizing It?

Area of Science:

• Hepatology
• Oncology
• Medical Imaging

Background:

• International guidelines advocate 6-monthly ultrasound surveillance for hepatocellular carcinoma (HCC) in cirrhosis patients.
• This study examines HCC screening adherence and outcomes in the UK's largest reported cirrhosis cohort.

Purpose of the Study:

• To evaluate the effectiveness of HCC surveillance in a large UK cirrhosis cohort.
• To identify predictors of surveillance adherence and analyze detection outcomes.

Main Methods:

• Retrospective review of cirrhotic patients eligible for HCC screening (n=898) at three London teaching hospitals.
• Categorization of patients into 'routine' or 'overdue' for surveillance, with analysis of non-adherence reasons.
• Univariate and multivariate analyses to identify clinical and sociodemographic surveillance predictors.

Main Results:

• Only 65% of eligible patients received HCC surveillance within the recommended 6-month period.
• Hepatocellular carcinoma (HCC) was detected in 6.8% of the cohort (61 cases).
• HCCs diagnosed via surveillance showed no significantly superior outcomes compared to incidentally detected cases.

Conclusions:

• HCC surveillance in this UK cirrhosis cohort is suboptimal and likely reflects broader national practice.
• Current surveillance strategies may not be improving patient outcomes significantly.
• Further research is needed to optimize HCC screening protocols for improved early detection and patient prognosis.